Results 181 to 190 of about 306,917 (239)

SGLT2i use and fracture risk compared with DPP4i in patients with T2DM

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy after prior dipeptidyl peptidase‐4 inhibitor (DPP4i) use.
Sung‐Yen Lin   +5 more
wiley   +1 more source

Intensive preoperative glucose management including hospitalization is associated with lower surgical site infection in patients with diabetes: A retrospective multicenter observational study

open access: yesJournal of Diabetes Investigation, EarlyView.
Preoperative hospitalization for glucose management was associated with a lower risk of surgical site infection in patients with diabetes who underwent surgery under general anesthesia. ABSTRACT Aims Perioperative glycemic control reduces surgical complications, such as surgical site infection (SSI), but evidence regarding the effect of preoperative ...
Yosuke Horikiri   +13 more
wiley   +1 more source

Long‐term effects of tofogliflozin on renal function in patients with type 2 diabetes: A retrospective multicenter study

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims To investigate the long‐term renal effects of tofogliflozin, with the shortest half‐life among sodium–glucose cotransporter 2 inhibitors, in real‐world clinical practice. Materials and methods We retrospectively enrolled patients with type 2 diabetes mellitus treated at three affiliated hospitals between January 2015 and May 2024.
Natsuko Shinagawa   +13 more
wiley   +1 more source

Evidence Map Analysis on Randomized Controlled Trials: Chinese Patent Medicines and Classic Traditional Chinese Medicine Prescriptions

open access: yesJournal of Evidence-Based Medicine, EarlyView.
ABSTRACT Objectives To evaluate the status and methodological quality of randomized controlled trials published in 2024 on Chinese patent medicines and Classic Traditional Chinese Medicine Prescriptions, providing evidence for clinical practice and policy.
Xiaolei Wu   +14 more
wiley   +1 more source

Periodontitis and Diabetes: Mechanistic Evidence of a Circular Relationship

open access: yesJournal of Periodontal Research, EarlyView.
This narrative review aimed to explore the underlying mechanisms that connect periodontitis to diabetes (and vice versa) and that influence disease susceptibility, progression and response to treatment. ABSTRACT The circular relationship between periodontitis and diabetes mellitus is one of the most established oral‐systemic links.
Philip M. Preshaw   +4 more
wiley   +1 more source

Australian Guideline for the Identification and Management of Hypertension in Children and Adolescents

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
N. G. Larkins   +28 more
wiley   +1 more source

Diabetic nephropathy

Clinical Cornerstone, 2003
As the epidemic of diabetes spreads so does the number of patients at risk for developing diabetic nephropathy, which occurs in 20% to 40% of all diabetic patients. Indeed, diabetes is the most common cause of end-stage renal disease (ESRD) in the United States, accounting for > 40% of patients starting renal replacement therapy each year ...
Mark E, Molitch   +5 more
openaire   +4 more sources

Diabetic nephropathy

Best Practice & Research Clinical Endocrinology & Metabolism, 1999
Diabetic nephropathy remains a leading cause of end-stage renal disease (ESRD) in western societies, accounting for over one-third of all patients beginning renal replacement therapy. Patients with Type 2 diabetes comprise the largest and fastest-growing single disease group requiring renal support therapy.
H A, Ibrahim, J P, Vora
openaire   +4 more sources

Diabetes and nephropathy

Current Opinion in Internal Medicine, 2003
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
M Luiza, Caramori, Michael, Mauer
openaire   +2 more sources

Pyroptosis in diabetes and diabetic nephropathy

Clinica Chimica Acta, 2022
Pyroptosis is identified as a pro-inflammatory programmed cell death, mediated by gasdermins (GSDMs) family of proteins accompanied by pro-inflammatory signals release. As essential players in innate immunity, inflammasomes are intracellular protein complexes which cleave gasdermin D (GSDMD), forming structurally stable pores in the cell membrane ...
Zhaohui, Cao   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy